septic
shock
defin
subset
sepsi
characteris
adequ
volum
resuscit
need
vasopressor
order
maintain
normal
mean
arteri
pressur
map
mmhg
myocardi
dysfunct
commonli
seen
sepsi
also
involv
right
ventricl
rv
number
studi
rv
function
sepsi
convent
echocardiographi
limit
use
american
societi
echocardiographi
criteria
rv
dysfunct
describ
septic
shock
furthermor
recent
shown
incid
isol
right
combin
right
left
ventricular
dysfunct
sepsissept
shock
respect
norepinephrin
administr
increas
arteri
pressur
due
vasoconstrictor
effect
recommend
firstchoic
vasopressor
group
patient
concern
rais
regard
potenti
neg
effect
norepinephrin
myocardi
function
due
norepinephrineinduc
increas
left
ventricular
lv
afterload
rv
afterload
frequent
elev
background
observ
studi
effect
norepinephrineinduc
chang
mean
arteri
pressur
map
right
ventricular
rv
systol
function
afterload
pulmonari
haemodynam
studi
septic
shock
patient
hypothesis
rv
systol
function
improv
higher
dose
norepinephrin
map
level
method
eleven
patient
septic
shock
requir
norepinephrin
fluid
resuscit
includ
hour
icu
arriv
studi
enrol
insert
pulmonari
arteri
cathet
perform
written
inform
consent
next
kin
norepinephrin
infus
titrat
target
mean
arteri
pressur
map
mmhg
random
sequenti
order
target
map
strainand
convent
echocardiographicand
pulmonari
haemodynam
variabl
measur
rv
afterload
assess
effect
pulmonari
arteri
elast
e
pa
pulmonari
vascular
resist
index
pvri
rv
free
wall
peak
strain
primari
endpoint
highest
compar
lowest
norepinephrin
dosemap
level
rv
free
wall
peak
strain
increas
p
accompani
increas
tricuspid
annular
plane
systol
excurs
p
highest
norepinephrin
dosemap
rv
enddiastol
area
index
p
central
venou
pressur
p
stroke
volum
index
p
mean
pulmonari
arteri
pressur
p
rv
stroke
work
index
p
increas
effect
pvri
e
pa
cardiac
index
chang
assess
thermodilut
p
echocardiographi
p
higher
dose
norepinephrin
target
map
mm
hg
improv
rv
systol
function
rv
afterload
affect
addit
support
inform
may
found
onlin
support
inform
section
end
articl
se
impact
norepinephrin
right
ventricular
afterload
function
septic
shocka
strain
echocardiographi
studi
sepsi
due
increas
pulmonari
vascular
resist
pvr
particularli
septic
patient
associ
acut
lung
injuri
requir
mechan
ventil
norepinephrin
potenti
increas
rv
afterload
alphamedi
pulmonari
vasoconstrict
septic
patient
hand
norepinephrin
may
increas
rv
systol
function
receptor
agonist
effect
addit
norepinephrin
shown
increas
rv
lv
preload
alphamedi
constrict
system
venou
capacit
vessel
caus
increas
intrathorac
blood
volum
strain
echocardiographi
rel
new
promis
method
assess
myocardi
systol
function
differenti
activ
passiv
scar
movement
myocardi
segment
speckletrack
echocardiographi
measur
rel
movement
myocardi
greyscal
alter
speckl
pattern
therebi
quantifi
systol
deform
strain
describ
percentag
chang
myocardi
segment
length
frequent
use
strain
variabl
global
longitudin
strain
gl
introduc
detect
lv
dysfunct
sepsi
strain
imag
abil
detect
impair
lv
systol
function
appreci
convent
echocardiographi
rv
systol
function
also
evalu
strain
echocardiographi
assess
rv
free
wall
strain
sepsissept
shock
shown
rv
free
wall
peak
strain
consider
reduc
sever
reduc
rv
free
wall
strain
associ
increas
mortal
aim
investig
immedi
effect
chang
norepinephrin
infus
ratesmap
level
rv
systol
function
rv
afterload
patient
septic
shock
combin
use
strain
echocardiographi
pulmonari
arteri
thermodilut
cathet
assess
pulmonari
haemodynam
test
hypothesi
higher
norepinephrin
infus
rate
map
level
improv
rv
systol
function
patient
norepinephrinedepend
septic
shock
despit
potenti
increas
rv
afterload
studi
approv
region
ethic
review
board
gothenburg
wwwepns
protocol
approv
june
studi
regist
clinicaltrialsgov
decemb
data
first
part
protocol
present
written
inform
consent
obtain
patient
next
kin
includ
patient
admit
septic
shock
gen
systol
sap
mean
map
diastol
arteri
blood
pressur
measur
invas
radial
arteri
cathet
patient
underw
catheteris
pulmonari
arteri
cathet
pac
baxter
healthcar
irvin
ca
purpos
studi
protocol
cardiac
output
co
stroke
volum
measur
thermodilut
techniqu
pac
mean
three
icecold
salin
inject
index
bodi
surfac
area
receiv
cardiac
index
ci
stroke
volum
index
svi
coeffici
variat
co
measur
patient
heart
rate
hr
arteri
blood
pressur
systol
mean
pulmo
e
pa
incorpor
element
total
rv
afterload
includ
vascular
resist
arteri
complianc
characterist
imped
strain
measur
perform
offlin
fourchamb
longaxi
twochamb
view
offlin
analys
per
insert
pulmonari
arteri
cathet
norepinephrin
dose
adjust
obtain
target
mean
arteri
pressur
map
mmhg
baselin
measur
system
pulmonari
haemodynam
well
echocardiograph
examin
perform
twice
target
map
patient
subject
target
map
mmhg
random
order
period
least
minut
exclud
washinwashout
period
decreasingincreas
infus
rate
norepinephrin
figur
washinwashout
period
last
approxim
minut
one
investig
perform
haemodynam
measur
dose
adjust
anoth
echocardiograph
examin
blind
find
end
period
haemodynam
echocardiograph
measur
perform
fluid
infus
rate
ventilatori
set
chang
experiment
procedur
two
baselin
measur
intraobserv
agreement
variabl
rv
free
wall
peak
strain
lv
global
longitudin
strain
assess
coeffici
variat
pair
observ
interobserv
variat
assess
mean
first
second
measur
baselin
calcul
baselin
primari
outcom
variabl
rv
free
wall
peak
strain
detect
norepinephrineinduc
rel
chang
rv
free
wall
peak
strain
highest
compar
lowest
eleven
patient
includ
studi
male
femal
mean
age
tabl
patient
studi
within
hour
icu
arriv
hour
mean
sap
score
sofa
score
icu
arriv
respect
patient
characterist
clinic
data
sourc
infect
mortal
present
tabl
none
patient
receiv
vasopressor
inotrop
drug
norepinephrin
data
normal
distribut
test
kolmogorovsmirnov
test
dose
norepinephrin
obtain
target
map
mmhg
respect
highest
compar
lowest
norepinephrin
dosemap
level
accompani
increas
svi
p
anova
mpap
p
pcwp
p
cvp
p
svri
p
lvswi
p
rvswi
p
decreas
pvrisvri
ratio
p
pvri
heart
rate
affect
norepinephrin
infus
ratemap
level
neither
co
p
ci
p
chang
significantli
compar
highest
lowest
norepinephrin
dosemap
level
e
increas
p
e
pa
significantli
affect
norepinephrinemap
level
p
patient
sinu
rhythm
perform
experiment
protocol
tabl
figur
baselin
mmhg
ventilatorinduc
variat
sv
assess
echocardiographi
data
rv
free
wall
peak
strain
rvedai
miss
one
patient
impair
rv
function
seen
patient
baselin
mmhg
highest
compar
lowest
norepinephrin
dosemap
level
accompani
improv
rv
systol
function
reflect
chang
rv
free
wall
peak
strain
p
anova
increas
taps
p
increas
tricuspid
annular
systol
veloc
p
rvedai
increas
significantli
p
svi
increas
p
neither
co
p
ci
p
lvedv
p
chang
significantli
higher
dose
norepinephrinemap
level
lv
eject
fraction
lv
gl
affect
higher
dose
norepinephrinemap
level
tabl
figur
figur
intraobserv
coeffici
variat
pair
measur
rv
free
wall
peak
strain
lv
global
longitudin
strain
respect
main
find
rv
function
improv
increas
dose
norepinephrin
assess
strain
convent
echocardiographi
furthermor
neither
pvri
effect
pulmonari
arteri
elast
e
pa
measur
total
rv
afterload
previous
shown
rv
free
wall
strain
patient
without
cardiopulmonari
diseas
rang
mean
present
studi
patient
rv
free
wall
strain
mean
baselin
mmhg
suggest
rv
function
compromis
confirm
previou
strain
echocardiograph
studi
patient
sever
sepsi
ventricular
strain
loaddepend
myocardi
deform
variabl
sensit
chang
preload
shown
clinic
strain
echocardiograph
studi
furthermor
increas
inotrop
stimul
increas
ventricular
strain
also
preload
afterload
control
present
studi
neassoci
improv
rv
free
wall
strain
like
caus
increas
rv
preload
less
posit
receptormedi
inotrop
effect
could
also
contribut
improv
rv
perform
norepinephrin
lv
contract
may
also
contribut
rv
eject
mediat
septal
contract
although
measur
degre
septal
contract
present
studi
believ
unlik
improv
rv
systol
function
induc
norepinephrin
caus
enhanc
septal
contract
norepinephrin
induc
chang
lv
systol
function
attribut
benefici
effect
norepinephrin
restor
low
diastol
arteri
pressur
would
improv
coronari
perfus
lv
perform
andor
norepinephrineinduc
stimul
upregul
adrenerg
receptor
major
limit
present
studi
small
number
patient
prolong
inclus
window
low
inclus
ratio
screen
patient
risk
indic
select
spectrum
bia
anoth
limit
lowest
map
mmhg
use
present
studi
support
guidelin
manag
septic
shock
mmhg
anoth
limit
studi
acut
effect
ne
cardiac
function
pulmonari
haemodynam
therefor
draw
conclus
potenti
longterm
effect
norepinephrin
variabl
septic
shock
strength
studi
data
rv
lv
deform
well
pulmonari
system
haemodynam
includ
pulmonari
vascular
resist
rv
lv
arteri
elast
rv
lv
preload
simultan
obtain
patient
conclud
cohort
septic
shock
patient
variat
norepinephrin
infus
rate
achiev
target
map
rang
mmhg
appear
lead
increas
rv
free
wall
peak
systol
strain
find
indic
better
right
ventricular
systol
function
higher
norepinephrin
infus
ratesmap
level
mechan
behind
improv
could
increas
rv
preload
caus
norepinephrineinduc
venoconstrict
increas
myocardi
contractil
togeth
neutral
effect
norepinephrin
pulmonari
vascular
resist
rv
afterload
studi
support
grant
swedish
state
agreement
swedish
govern
counti
council
alfagr
gothenburg
medic
societi
none
author
conflict
interest
declar
http
svenerik
ricksten
http
